OR WAIT null SECS
Check out the latest features and columns!
Pharm Exec profiles its 2022 Emerging Pharma Leaders
Biopharma experts at the forefront of applying real-world data and real-world evidence across the product life cycle converge to discuss the lingering challenges in fully realizing the vast potential of these insights to transform the value equation
June's Executive Profile features Tremeau CEO, Bradford Sippy
The windfall from COVID-19 vaccines and treatments has shaken up Pharm Exec’s latest listing of the top global biopharma sales producers in record-breaking fashion
Highlighted Videos
June 30, 2022
Inizio will act as a strategic partner to health and life science companies throughout the life cycle of their drug products.
June 29, 2022
As director of corporate strategy for Novartis, Kamenska defines direction for the company’s overall enterprise. Here, she discusses how the pandemic and recent market events are shaping these strategies.
DiMambro discusses how companies can update their systems and strategies to collect data which ensures that marginalized groups and diverse voices are included.
Employees must be able to retain information and remain engaged to keep pace with highly regulated industry.
Nexus Pharmaceuticals' Chief Strategy Officer Omair Ahmed discusses their APEX-award winning EMERPHED™ campaign, which built on the ideas of simplification, safety and stability to enhance their hospital-delivered product and support their field sales reps.
June 28, 2022
Board Certified Biologics and Biosimilars Specialist (BCBBS) program will launch in 2022.
June 27, 2022
Amid push to include this population more in clinical trials, the goal is to uncover improved evidence on the risks/benefits of drugs for these patients.
June 24, 2022
Takes aim at actions that limit access to lower-cost drugs, calls for revamp of M&A-impact guidelines.
June 23, 2022
In episode 111, Kevin Ali, CEO of Organon, talks about how’s he’s lead the launch of a new niche company for women’s health, and what he hopes it can achieve.
June 22, 2022
Mr. Horvath, who brings over a decade of experience in pharmaceutical commercialization, will lead the commercialization of POINT’s pipeline.
